WSJ Says FTC Increasingly Unlikely to Block Deal Between Medco (MHS), Express Scripts (ESRX)
Tweet Send to a FriendGet Alerts MHS Hot Sheet
Trade MHS Now!
Medco (NYSE: MHS) shares are ticking higher over just the last few minutes of trade as WSJ is reporting the FTC is becoming increasingly unlikely to block the deal between the company and Express Scripts (Nasdaq: ESRX).
Shares of Medco last traded at $68.30, up about 1 percent from Thursday's close.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Shares of Medco last traded at $68.30, up about 1 percent from Thursday's close.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: ViroPharma (VPHM) on the Move Following Takeover Chatter - Reuters
- Columbia Pacific Approached Vitesse Semi (VTSS) About Possible Takeover
- Datawatch (DWCH) to Acquire Panopticon Software in $31.4M Deal
Create E-mail Alert Related Categories
Mergers and Acquisitions, Momentum Movers, Rumors
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
